Copyright: ©Author(s) 2026.
World J Gastrointest Surg. Nov 27, 2026; 18(11): 123131
Published online Nov 27, 2026. doi: 10.4240/wjgs.123131
Published online Nov 27, 2026. doi: 10.4240/wjgs.123131
Table 3 Comparison of postoperative glucose metabolism related indicators between the two groups, n (%)/mean ± SD
| Index | Combined group (n = 60) | Control group (n = 60) | t/χ² | P value |
| Mean blood glucose (mmol/L) | 8.7 ± 1.4 | 8.5 ± 1.3 | 0.802 | 0.424 |
| Blood glucose CV (%) | 24.5 ± 4.1 | 23.2 ± 3.8 | 0.997 | 0.318 |
| Average daily insulin dosage (U/day) | 38.6 ± 9.2 | 37.4 ± 8.8 | 0.735 | 0.463 |
| Number of hypoglycemic events | 1 (1.7) | 0 (0.0) | 1.008 | 0.315 |
- Citation: Abudouhadier K, Xu JQ, Lin H. Value of pancreatic duct stent placement combined with octreotide for reducing the postoperative pancreatic fistula rate in patients with diabetes undergoing pancreaticoduodenectomy. World J Gastrointest Surg 2026; 18(11): 123131
- URL: https://www.wjgnet.com/1948-9366/full/v18/i11/123131.htm
- DOI: https://dx.doi.org/10.4240/wjgs.123131